Prosthetic heart valve therapy is carried out for the patients suffering from the valvular heart disorder. Heart valve replacement was carried out in the early 1960s. It is reported that more than 280,000 heart valve replacement cases had been observed worldwide.
Prosthetic heart valve is a cardiac surgery to replace a diseased heart valve by an artificial heart valve. Replacement of abnormal valves with prosthetic heart valves decreases the mortality and morbidity related with cardiac valve disorders. Technical advancement and growing frequency of heart valve diseases are main factors which drive the prosthetic heart valves market. Condition connected with heart valve disorders are congenital defect and acquire disorders. Some of the technology for prosthetic heart valves is polymers, transcatheter valves, suture-less valves anti-calcification technology, and carbon-based technologies.
How Big is the Global Prosthetic Heart Valves Market?
The Global Prosthetic Heart Valves Market is expected to be around US$ 16 Billion by 2028; Growing at a CAGR of more than 12.5% in the given forecast period.
The major driving factors of Global Prosthetic Heart Valves Market are as follows:
• Increasing healthcare expenditure
• Growing awareness regarding the diagnosis and accessibility of treatments for heart valve disorder
• Increase in the number of heart surgeries
The restraining factors of Global Prosthetic Heart Valves Market are as follows:
• Lack of skilled professionals
• Strict government regulations
• High cost of development and reimbursement issues
The Global Prosthetic Heart Valves Market is segmented on the lines of its product and regional. Based on product segmentation it covers mechanical heart valve, transcatheter heart valve and tissue heart valve. The prosthetic heart valves market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Prosthetic Heart Valves Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Prosthetic Heart Valves Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various Prosthetic Heart Valves Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Edwards Lifesciences, Medtronic, ON-X LIFE TECHNOLOGIES, INC., Abbott Laboratories, and St. Jude Medical. In addition, some of the other companies operating in the global prosthetic heart valves market are CryoLife, Sorin Group, LepuMedical, and Braile Biomedica, Ltd. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Prosthetic Heart Valves Market has been segmented as below:
By Product Segment Analysis
• Mechanical Heart Valve
• Transcatheter Heart Valve
• Tissue Heart Valve
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all prosthetic heart valves.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of prosthetic heart valves data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Automated Breast Ultrasound System market
Automated Compounding System market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Integrated Ecosystem of Prosthetic Heart Valve Market
2.1.1 Top-Down Approach
2.1.2 Bottom-Up Approach
2.1.3 Demand-Side Approach
2.2 Product Matrix
2.3 Assumptions
3 Executive Summary
4 Market Overview
4.1 Market: Comparison With Cardiac Medical Devices (Parent Market)
4.2 Market Drivers and Inhibitors
4.3 Key Market Dynamics
5 Prosthetic Heart Valve Market, By Type
5.1 Introduction
5.2 Mechanical Heart Valve
5.3 Tissue Heart Valve
5.4 Transcatheter Heart Valve
6 Prosthetic Heart Valve Market, By Geography
6.1 Introduction
6.2 Americas
6.2.1 By Country
6.2.1.1 U.S.
6.2.1.2 Canada
6.2.1.3 Brazil
6.2.1.4 Mexico
6.2.1.5 Argentina
6.2.1.6 Colombia
6.2.1.7 Chile
6.2.1.8 Paraguay
6.2.1.9 Uruguay
6.2.2 By Type
6.3 Europe
6.3.1 By Country
6.3.1.1 Germany
6.3.1.2 France
6.3.1.3 U.K.
6.3.1.4 Spain
6.3.1.5 Italy
6.3.1.6 Netherlands
6.3.1.7 Turkey
6.3.1.8 Belgium
6.3.1.9 Switzerland
6.3.1.10 Russia
6.3.1.11 Denmark
6.3.2 By Type
6.4 Asia-Pacific (APAC)
6.4.1 By Country
6.4.1.1 Japan
6.4.1.2 China
6.4.1.3 Australia
6.4.1.4 India
6.4.1.5 Republic of Korea
6.4.1.6 New Zealand
6.4.1.7 Singapore
6.4.1.8 Thailand
6.4.1.9 Malaysia
6.4.1.10 Vietnam
6.4.1.11 Taiwan
6.4.1.12 Indonesia
6.4.2 By Type
6.5 Middle East Africa (MEA)
6.5.1 By Country
6.5.1.1 Egypt
6.5.1.2 Saudi Arabia
6.5.1.3 United Arab Emirates (UAE)
6.5.1.4 South Africa
6.5.1.5 Libya
6.5.1.6 Algeria
6.5.1.7 Kenya
6.5.1.8 Kuwait
6.5.1.9 Jordan
6.5.1.10 Sudan
6.5.1.11 Morocco
6.5.1.12 Tunisia
6.5.1.13 Israel
6.5.1.14 Zimbabwe
6.5.1.15 Mauritius
6.5.1.16 Oman
6.5.2 By Type
7 Competitive Landscape
7.1 Company Share Analysis : Prosthetic Heart Valves Market
7.1.1 U.S.
7.1.2 Canada
7.1.3 Brazil
7.1.4 Germany
7.1.5 France
7.1.6 U.K.
7.1.7 China
7.1.8 India
7.1.9 Japan
7.2 New Product Launches
7.3 Mergers and Acquisitions
7.4 Collaborations, Joint Agreements & Expansions, Partnership
7.5 Approvals, Alliances, Relocations & Licensing, and New Brand Strategy
8 Company Profiles
8.1 Abbott Laboratories
8.2 Boston Scientific Corporation
8.3 Medtronic
8.4 ST. Jude Medical, Inc.
8.5 Edwards Lifesciences Corporation
8.6 Sorin S.P.A.
8.7 Neovasc Inc.
8.8 Colibri Heart Valve, LLC
8.9 On-X Life Technologies Inc.
8.10 Symetis
8.11 Cytograft
8.12 Jenavalve Technology
The Global Prosthetic Heart Valves Market has been segmented as below:
By Product Segment Analysis
• Mechanical Heart Valve
• Transcatheter Heart Valve
• Tissue Heart Valve
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
